CA Patent

CA3085221A1 — Methods of treating residual lesions of vascular anomalies

Assigned to Georgetown University · Expires 2019-06-20 · 7y expired

What this patent protects

Compositions comprising bile acids or their salts and methods of use thereof for the treatment of residual lesions of vascular anomalies.

USPTO Abstract

Compositions comprising bile acids or their salts and methods of use thereof for the treatment of residual lesions of vascular anomalies.

Drugs covered by this patent

Patent Metadata

Patent number
CA3085221A1
Jurisdiction
CA
Classification
—
Expires
2019-06-20
Drug substance claim
No
Drug product claim
No
Assignee
Georgetown University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.